Is RBC Bioscience stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, RBC Bioscience pays dividends. Last time was Friday 18th of October 2024 where the investors holding the stock on Thursday 19th of September 2024 were paid TWD0.56 per share. Over the last 4 times between 2022 and 2024, RBC Bioscience has paid TWD3.22 with an average of TWD0.81 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for RBC Bioscience 10 years ago, but if you had invested on Monday 25th of October 2021 when the price was TWD48.73, you would have made a loss of TWD-29.08 per share or -59.68%
No, the average daily trading liquidity for RBC Bioscience is TWD25 917 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
RBC Bioscience has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.10, the company's ability to pay off the debt is limited. RBC Bioscience has a good net profit margin of 8.87% and should have high tolerances against inflation.
We have calculated the inflation risk for RBC Bioscience to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.